Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical Trials

Despite effective therapies for smoking cessation, most smokers find quitting difficult and most successful quitters relapse. Considerable evidence supports a genetic risk for nicotine dependence; however, less is known about the pharmacogenetics of smoking cessation. In the first pharmacogenetic in...

Descripción completa

Detalles Bibliográficos
Autores principales: King, David P, Paciga, Sara, Pickering, Eve, Benowitz, Neal L, Bierut, Laura J, Conti, David V, Kaprio, Jaakko, Lerman, Caryn, Park, Peter W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260990/
https://www.ncbi.nlm.nih.gov/pubmed/22048466
http://dx.doi.org/10.1038/npp.2011.232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260990/
https://www.ncbi.nlm.nih.gov/pubmed/22048466
http://dx.doi.org/10.1038/npp.2011.232

Ejemplares similares